Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$1.90 USD
-0.09 (-4.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.93 +0.03 (1.58%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | 5.66% |
ABR | 1.88 |
Earnings ESP
|
268.68% |
---|---|
Current Year | -0.68 |
Next Year | 0.31 |
EPS (TTM) | -2.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 53.11M | 40.73M | 227.91M | 467.38M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 136.36M | 44.51M | 317.24M | 710.20M |
Low Estimate | 30.20M | 38.00M | 174.00M | 353.70M |
Year ago Sales | 24.33M | 25.79M | 116.33M | 227.91M |
Year over Year Growth Est. | 118.31% | 57.91% | 95.91% | 105.07% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.23 | -0.68 | 0.31 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.38 | -0.25 | -0.95 | 0.05 |
High Estimate | 0.28 | -0.20 | -0.17 | 1.49 |
Low Estimate | -0.38 | -0.25 | -1.00 | -0.23 |
Year ago EPS | -0.79 | -0.46 | -2.03 | -0.68 |
Year over Year Growth Est. | 78.48% | 50.00% | 66.50% | 144.41% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.23 | -0.68 | 0.31 |
7 Days Ago | -0.17 | -0.23 | -0.68 | 0.31 |
30 Days Ago | -0.29 | 0.01 | -0.61 | 0.34 |
60 Days Ago | -0.32 | 0.14 | -0.12 | 0.70 |
90 Days Ago | -0.36 | 0.08 | -0.25 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.28 | -0.22 | -0.56 | 0.07 |
Zacks Consensus Estimate | -0.17 | -0.23 | -0.68 | 0.31 |
Earnings ESP | 268.68% | 2.66% | 17.16% | -77.12% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | -0.37 | -0.46 | -0.79 | NA |
Estimate | -0.53 | -0.42 | -0.63 | -0.65 | NA |
Difference | 0.03 | 0.05 | 0.17 | -0.14 | 0.03 |
Surprise | 5.66% | 11.90% | 26.98% | -21.54% | 5.75% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more